-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the "Administrative Measures for the Classification of Prescription Drugs and Over-the-Counter Drugs (Trial)" (formerly State Drug Administration Order No.
Before July 6, 2021, the holder of the relevant drug marketing authorization shall submit a supplementary application for the revision of the drug label in accordance with the "Administrative Measures on Drug Registration" and other relevant regulations, and submit it to the provincial drug regulatory authority for record, and promptly notify the relevant contents of the revision of the label Medical institutions, pharmaceutical companies and other units
The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents
Hereby announce
Attachment: 1.
2.
State Food and Drug Administration
April 7, 2021
Announcement No.
Annex 2 of the Announcement No.